Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Larry Norton

Showing results (91-100 of 293) with videos related to

Pageof 30
Sort By:
Cancer Cell|July 4, 2009
Latent bone metastasis in breast cancer tied to Src-dependent survival signalsXiang H-F Zhang, Qiongqing Wang, William Gerald, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2008
Phase I study of a novel capecitabine schedule based on the Norton-Simon mathematical model in patients with metastatic breast cancerTiffany A Traina, Maria Theodoulou, Kimberly Feigin, et al.
Nature|March 9, 2007
Keeping faith with trial volunteersMartine Piccart, Aron Goldhirsch, William Wood, et al.
NPJ Breast Cancer|July 20, 2017
Spatiotemporal progression of metastatic breast cancer: a Markov chain model highlighting the role of early metastatic sitesPaul K Newton, Jeremy Mason, Neethi Venkatappa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 24, 2007
American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancerLyndsay Harris, Herbert Fritsche, Robert Mennel, et al.
Cancer|August 27, 2004
Cytokeratin-positive cells in sentinel lymph nodes in breast cancer are not random events: experience in patients undergoing prophylactic mastectomyTari A King, Archana Ganaraj, Jane V Fey, et al.
Cancer|June 18, 2011
Adjuvant trastuzumab with chemotherapy is effective in women with small, node-negative, HER2-positive breast cancerHeather L McArthur, Kathleen M Mahoney, Patrick G Morris, et al.
Cancer|March 10, 2011
Phase 2 trial of a novel capecitabine dosing schedule in combination with bevacizumab for patients with metastatic breast cancerDevika Gajria, Kim Feigin, Lee K Tan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 4, 2017
American Society of Clinical Oncology Position Statement: Strategies for Reducing Cancer Health Disparities Among Sexual and Gender Minority PopulationsJennifer Griggs, Shail Maingi, Victoria Blinder, et al.
The Lancet. Oncology|August 20, 2021
The impact of scaling up access to treatment and imaging modalities on global disparities in breast cancer survival: a simulation-based analysisZachary J Ward, Rifat Atun, Hedvig Hricak, et al.
Pageof 30

Showing results (91-100 of 293) with videos related to

Sort By:
Pageof 30
Cancer Cell|July 4, 2009
Latent bone metastasis in breast cancer tied to Src-dependent survival signalsXiang H-F Zhang, Qiongqing Wang, William Gerald, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2008
Phase I study of a novel capecitabine schedule based on the Norton-Simon mathematical model in patients with metastatic breast cancerTiffany A Traina, Maria Theodoulou, Kimberly Feigin, et al.
Nature|March 9, 2007
Keeping faith with trial volunteersMartine Piccart, Aron Goldhirsch, William Wood, et al.
NPJ Breast Cancer|July 20, 2017
Spatiotemporal progression of metastatic breast cancer: a Markov chain model highlighting the role of early metastatic sitesPaul K Newton, Jeremy Mason, Neethi Venkatappa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 24, 2007
American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancerLyndsay Harris, Herbert Fritsche, Robert Mennel, et al.
Cancer|August 27, 2004
Cytokeratin-positive cells in sentinel lymph nodes in breast cancer are not random events: experience in patients undergoing prophylactic mastectomyTari A King, Archana Ganaraj, Jane V Fey, et al.
Cancer|June 18, 2011
Adjuvant trastuzumab with chemotherapy is effective in women with small, node-negative, HER2-positive breast cancerHeather L McArthur, Kathleen M Mahoney, Patrick G Morris, et al.
Cancer|March 10, 2011
Phase 2 trial of a novel capecitabine dosing schedule in combination with bevacizumab for patients with metastatic breast cancerDevika Gajria, Kim Feigin, Lee K Tan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 4, 2017
American Society of Clinical Oncology Position Statement: Strategies for Reducing Cancer Health Disparities Among Sexual and Gender Minority PopulationsJennifer Griggs, Shail Maingi, Victoria Blinder, et al.
The Lancet. Oncology|August 20, 2021
The impact of scaling up access to treatment and imaging modalities on global disparities in breast cancer survival: a simulation-based analysisZachary J Ward, Rifat Atun, Hedvig Hricak, et al.
Pageof 30